Daniel Dolan | CFO |
Theodore Schroeder | CEO |
Carl Byrnes | Northland Capital Markets |
Ed Arce | H.C. Wainwright |
Welcome to the Nabriva Therapeutics Third Quarter 2022 Financial Results Call and Corporate Update. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Mr. Dan Dolan, CFO. Please go ahead.